(Q37578500)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1 reference

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Asmaa Ibrahim Gomaa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Simon D Taylor-Robinson

6

object named as

Simon D Taylor-Robinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Mohamed I F Shariff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Shahid A Khan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Wladyslaw Gedroyc

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Gastroenterology & Hepatology

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

353-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

Estimating the world cancer burden: Globocan 2000.

5 February 2020

cites work

1 reference

Global cancer statistics in the year 2000.

21 January 2018

1 reference

Hepatocellular carcinoma: recent trends in the United States

21 January 2018

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

Changing international trends in mortality rates for liver, biliary and pancreatic tumours

21 January 2018

1 reference

Global epidemiology of hepatitis B virus

21 January 2018

1 reference

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004.

21 January 2018

1 reference

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells

21 January 2018

1 reference

Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways

21 January 2018

1 reference

Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level

21 January 2018

1 reference

Hepatocellular carcinoma. A worldwide problem and the major risk factors

21 January 2018

1 reference

Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities of the world--Trieste, Italy, and Chiba, Japan.

21 January 2018

1 reference

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications

21 January 2018

1 reference

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

21 January 2018

1 reference

Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study

21 January 2018

1 reference

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients

21 January 2018

1 reference

Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia.

21 January 2018

1 reference

Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors

21 January 2018

1 reference

Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice

21 January 2018

1 reference

Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.

21 January 2018

1 reference

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

21 January 2018

1 reference

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

21 January 2018

1 reference

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

21 January 2018

1 reference

Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.

21 January 2018

1 reference

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases

21 January 2018

1 reference

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

21 January 2018

1 reference

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

21 January 2018

1 reference

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

Global epidemiology of hepatitis C virus infection

21 January 2018

1 reference

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

HCV-associated liver cancer without cirrhosis

21 January 2018

1 reference

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

21 January 2018

1 reference

Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection

21 January 2018

1 reference

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era

21 January 2018

1 reference

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

Obesity and cancer risk: a Danish record-linkage study

21 January 2018

1 reference

A prospective study of obesity and cancer risk (Sweden).

21 January 2018

1 reference

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

21 January 2018

1 reference

The toxicology of aflatoxins as a basis for public health decisions

21 January 2018

1 reference

Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women

21 January 2018

1 reference

Mutations of the HFE gene in patients with hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study

21 January 2018

1 reference

Diagnosis of hepatocellular carcinoma.

21 January 2018

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Limitations of imaging diagnosis for small hepatocellular carcinoma: comparison with histological findings

21 January 2018

1 reference

Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma

21 January 2018

1 reference

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

21 January 2018

1 reference

alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma

21 January 2018

1 reference

Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

21 January 2018

1 reference

Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma

21 January 2018

1 reference

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

21 January 2018

1 reference

Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3

21 January 2018

1 reference

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size

21 January 2018

1 reference

PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.

21 January 2018

1 reference

Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis

21 January 2018

1 reference

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate

21 January 2018

1 reference

Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks

21 January 2018

1 reference

Proteomics for hepatocellular carcinoma marker discovery

21 January 2018

1 reference

Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease

21 January 2018

1 reference

A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma

21 January 2018

1 reference

Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis

21 January 2018

1 reference

Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy

21 January 2018

1 reference

21 January 2018

Imaging of liver cancer

1 reference

Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions

21 January 2018

1 reference

Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver.

21 January 2018

1 reference

Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning

21 January 2018

1 reference

Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis

21 January 2018

1 reference

Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.

21 January 2018

1 reference

Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.

21 January 2018

1 reference

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies

21 January 2018

1 reference

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

21 January 2018

1 reference

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

21 January 2018

1 reference

Chemoembolization for hepatocellular carcinoma

21 January 2018

1 reference

Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma

21 January 2018

1 reference

Anaesthesia for high intensity focused ultrasound (HIFU) therapy.

21 January 2018

1 reference

MR-guided laser thermal ablation of primary and secondary liver tumours

21 January 2018

1 reference

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma

21 January 2018

1 reference

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

21 January 2018

1 reference

Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.09.35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19673623%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference